Comprehensive characterization of monoclonal antibody by Fourier transform ion cyclotron resonance mass spectrometry

References

• Carter PJ, Lazar GA. 2017. Next generation antibody drugs: pursuit of the ‘high-hanging fruit’. Nat Rev Drug Discov. 17:197–223. doi:10.1038/nrd.2017.227.
   PubMed Web of Science ®Google Scholar
• Ecker DM, Jones SD, Levine HL. 2015. The therapeutic monoclonal antibody market. Mabs-Austin. 7:9–14. doi:10.4161/19420862.2015.989042.
   PubMed Web of Science ®Google Scholar
• Chames P, Van Regenmortel M, Weiss E, Baty D. 2009. Therapeutic antibodies: successes, limitations and hopes for the future. Br J Pharmacol. 157:220–233. doi:10.1111/j.1476-5381.2009.00190.x.
   PubMed Web of Science ®Google Scholar
• Weiner GJ. 2015. Building better monoclonal antibody-based therapeutics. Nat Rev Cancer. 15:361–370. doi:10.1038/nrc3930.
   PubMed Web of Science ®Google Scholar
• Kaplon H, Reichert JM. 2018. Antibodies to watch in 2018. Mabs-Austin. 10:183–203. doi:10.1080/19420862.2018.1415671.
   PubMed Web of Science ®Google Scholar
• Reichert JM. 2012. Marketed therapeutic antibodies compendium. Mabs-Austin. 4:413–415. doi:10.4161/mabs.19931.
   PubMed Web of Science ®Google Scholar
• Breedveld FC. Therapeutic monoclonal antibodies. Lancet. 355;2000:735–740.
   PubMed Web of Science ®Google Scholar
• Liu HC, Gaza-Bulseco G, Faldu D, Chumsae C, Sun J. 2008. Heterogeneity of monoclonal antibodies. J Pharm Sci-Us. 97:2426–2447. doi:10.1002/jps.21180.
   PubMed Web of Science ®Google Scholar
• Wang W, Singh S, Zeng DL, King K, Nema S. 2007. Antibody structure, instability, and formulation. J Pharm Sci-Us. 96:1–26. doi:10.1002/jps.20727.
   PubMed Web of Science ®Google Scholar
• Mukherjee R, Adhikary L, Khedkar A, Iyer H. 2010. Probing deamidation in therapeutic immunoglobulin gamma (IgG1) by ‘bottom-up’ mass spectrometry with electron transfer dissociation. Rapid Commun Mass Sp. 24:879–884. doi:10.1002/rcm.4464.
   PubMed Web of Science ®Google Scholar
• Ladwig PM, Barnidge DR, Willrich MAV. Mass spectrometry approaches for identification and quantitation of therapeutic monoclonal antibodies in the clinical laboratory. Clin Vaccine Immunol. 2017;24. doi:10.1128/CVI.00545-16.
   PubMed Web of Science ®Google Scholar
• Zhang ZQ, Pan H, Chen XY. 2009. Mass spectrometry for structural characterization of therapeutic antibodies. Mass Spectrom Rev. 28:147–176. doi:10.1002/mas.20190.
   PubMed Web of Science ®Google Scholar
• Rogstad S, Faustino A, Ruth A, Keire D, Boyne M, Park J. 2017. A retrospective evaluation of the use of mass spectrometry in FDA biologics license applications. J Am Soc Mass Spectr. 28:786–794. doi:10.1007/s13361-016-1531-9.
   PubMed Web of Science ®Google Scholar
• Beck A, Sanglier-Cianferani S, Van Dorsselaer A. 2012. Biosimilar, biobetter, and next generation antibody characterization by mass spectrometry. Anal Chem. 84:4637–4646. doi:10.1021/ac3002885.
   PubMed Web of Science ®Google Scholar
• Mazur MT, Seipert RS, Mahon D, Zhou QW, Liu T. 2012. A platform for characterizing therapeutic monoclonal antibody breakdown products by 2D chromatography and top-down mass spectrometry. Aaps J. 14:530–541. doi:10.1208/s12248-012-9361-6.
   PubMed Web of Science ®Google Scholar
• Beck A, Debaene F, Diemer H, Wagner-Rousset E, Colas O, Van Dorsselaer A, Cianferani S. Cutting-edge mass spectrometry characterization of originator, biosimilar and biobetter antibodies. J Mass Spectrom. 2015;50:285–297. doi:10.1002/jms.3554.
   PubMed Web of Science ®Google Scholar
• Ren D, Pipes GD, Liu DJ, Shih LY, Nichols AC, Treuheit MJ, Brems DN, Bondarenko PV. An improved trypsin digestion method minimizes digestion-induced modifications on proteins. Anal Biochem. 2009;392:12–21. doi:10.1016/j.ab.2009.05.018.
   PubMed Web of Science ®Google Scholar
• Chait BT. 2006. Mass spectrometry: bottom-up or top-down? Science. 314:65–66. doi:10.1126/science.1133987.
   PubMed Web of Science ®Google Scholar
• Smith LM, Kelleher NL, Proteomics CTD. 2013. Proteoform: a single term describing protein complexity. Nat Methods. 10:186–187. doi:10.1038/nmeth.2369.
   PubMed Web of Science ®Google Scholar
• Jin YT, Peng Y, Lin ZQ, Chen YC, Wei LM, Hacker TA, Larsson L, Ge Y. Comprehensive analysis of tropomyosin isoforms in skeletal muscles by top-down proteomics. J Muscle Res Cell M. 2016;37:41–52. doi:10.1007/s10974-016-9443-7.
   PubMed Web of Science ®Google Scholar
• Mao Y, Valeja SG, Rouse JC, Hendrickson CL, Marshall AG. 2013. Top-down structural analysis of an intact monoclonal antibody by electron capture Dissociation-Fourier Transform ion cyclotron resonance-mass spectrometry. Anal Chem. 85:4239–4246. doi:10.1021/ac303525n.
   PubMed Web of Science ®Google Scholar
• Tsybin YO, Fornelli L, Stoermer C, Luebeck M, Parra J, Nallet S, Wurm FM, Hartmer R. Structural analysis of intact monoclonal antibodies by electron transfer dissociation mass spectrometry. Anal Chem. 2011;83:8919–8927. doi:10.1021/ac201293m.
   PubMed Web of Science ®Google Scholar
• Nicolardi S, Deelder AM, Palmblad M, van der Burgt YEM. 2014. Structural analysis of an intact monoclonal antibody by online electrochemical reduction of disulfide bonds and Fourier Transform ion cyclotron resonance mass spectrometry. Anal Chem. 86:5376–5382. doi:10.1021/ac500383c.
   PubMed Web of Science ®Google Scholar
• Fornelli L, Damoc E, Thomas PM, Kelleher NL, Aizikov K, Denisov E, Makarov A, Tsybin YO. Analysis of intact monoclonal antibody IgG1 by electron transfer dissociation orbitrap FTMS. Mol Cell Proteomics. 2012;11:1758–1767. doi:10.1074/mcp.M112.019620.
   PubMed Web of Science ®Google Scholar
• Fornelli L, Ayoub D, Aizikov K, Beck A, Tsybin YO. 2014. Middle-down analysis of monoclonal antibodies with electron transfer dissociation orbitrap fourier transform mass spectrometry. Anal Chem. 86:3005–3012. doi:10.1021/ac4036857.
   PubMed Web of Science ®Google Scholar
• Cotham VC, Brodbelt JS. 2016. Characterization of therapeutic monoclonal antibodies at the subunit-level using middle-down 193 nm ultraviolet photodissociation. Anal Chem. 88:4004–4013. doi:10.1021/acs.analchem.6b00302.
   PubMed Web of Science ®Google Scholar
• Fornelli L, Srzentic K, Huguet R, Mullen C, Sharma S, Zabrouskov V, Fellers RT, Durbin KR, Compton PD, Kelleher NL. Accurate sequence analysis of a monoclonal antibody by top-down and middle-down orbitrap mass spectrometry applying multiple ion activation techniques. Anal Chem. 2018;90:8421–8429. doi:10.1021/acs.analchem.8b00984.
   PubMed Web of Science ®Google Scholar
• Jin YT, Wei LM, Cai WX, Lin ZQ, Wu ZJ, Peng Y, Kohmoto T, Moss RL, Ge Y. Complete characterization of cardiac myosin heavy chain (223 kDa) enabled by size-exclusion chromatography and middle-down mass spectrometry. Anal Chem. 2017;89:4922–4930. doi:10.1021/acs.analchem.7b00113.
   PubMedGoogle Scholar
• Cannon J, Lohnes K, Wynne C, Wang Y, Edwards N, Fenselau C. 2010. High-throughput middle-down analysis using an orbitrap. J Proteome Res. 9:3886–3890. doi:10.1021/pr1000994.
   PubMed Web of Science ®Google Scholar
• Siuti N, Kelleher NL. 2007. Decoding protein modifications using top-down mass spectrometry. Nat Methods. 4:817–821. doi:10.1038/nmeth1097.
   PubMed Web of Science ®Google Scholar
• He LD, Anderson LC, Barnidge DR, Murray DL, Hendrickson CL, Marshall AG. 2017. Analysis of monoclonal antibodies in human serum as a model for clinical monoclonal gammopathy by use of 21 Tesla FT-ICR top-down and middle-down MS/MS (vol 28, pg 827, 2017). J Am Soc Mass Spectr. 28:839. doi:10.1007/s13361-017-1652-9.
   PubMed Web of Science ®Google Scholar
• Kaltashov IA, Bobst CE, Abzalimov RR, Wang GB, Baykal B, Wang SH. 2012. Advances and challenges in analytical characterization of biotechnology products: mass spectrometry-based approaches to study properties and behavior of protein therapeutics. Biotechnol Adv. 30:210–222. doi:10.1016/j.biotechadv.2011.05.006.
   PubMed Web of Science ®Google Scholar
• Tran BQ, Barton C, Feng JH, Sandjong A, Yoon SH, Awasthi S, Liang T, Khan MM, Kilgour DPA, Goodlett DR, et al. Comprehensive glycosylation profiling of IgG and IgG-fusion proteins by top-down MS with multiple fragmentation techniques. J Proteomics. 2016;134:93–101. doi:10.1016/j.jprot.2015.10.021.
   PubMed Web of Science ®Google Scholar
• Zhang H, Cui WD, Gross ML. 2014. Mass spectrometry for the biophysical characterization of therapeutic monoclonal antibodies. Febs Lett. 588:308–317. doi:10.1016/j.febslet.2013.11.027.
   PubMed Web of Science ®Google Scholar
• Mann M, Kelleher NL. 2008. Precision proteomics: the case for high resolution and high mass accuracy. Proc Natl Acad Sci U S A. 105:18132–18138. doi:10.1073/pnas.0800788105.
   PubMed Web of Science ®Google Scholar
• Beck A, Wagner-Rousset E, Ayoub D, Van Dorsselaer A, Sanglier-Cianferani S. 2013. Characterization of therapeutic antibodies and related products. Anal Chem. 85:715–736. doi:10.1021/ac3032355.
   PubMed Web of Science ®Google Scholar
• Valeja SG, Kaiser NK, Xian F, Hendrickson CL, Rouse JC, Marshall AG. 2011. Unit mass baseline resolution for an intact 148 kDa therapeutic monoclonal antibody by Fourier Transform ion cyclotron resonance mass spectrometry. Anal Chem. 83:8391–8395. doi:10.1021/ac202429c.
   PubMed Web of Science ®Google Scholar
• Cai WX, Guner H, Gregorich ZR, Chen AJ, Ayaz-Guner S, Peng Y, Valeja SG, Liu XW, Ge Y. MASH Suite Pro: A comprehensive software tool for top-down proteomics. Mol Cell Proteomics. 2016;15:703–714. doi:10.1074/mcp.O115.054387.
   PubMed Web of Science ®Google Scholar
• Johnson KA, Paisley-Flango K, Tangarone BS, Porter TJ, Rouse JC. 2007. Cation exchange-HPLC and mass spectrometry reveal C-terminal amidation of an IgG1 heavy chain. Anal Biochem. 360:75–83. doi:10.1016/j.ab.2006.10.012.
   PubMed Web of Science ®Google Scholar
• Luo J, Zhang J, Ren DY, Tsai WL, Li F, Amanullah A, Hudson T. Probing of C-terminal lysine variation in a recombinant monoclonal antibody production using Chinese hamster ovary cells with chemically defined media. Biotechnol Bioeng. 2012;109:2306–2315. doi:10.1002/bit.24510.
   PubMed Web of Science ®Google Scholar
• Kaschak T, Boyd D, Lu F, Derfus G, Kluck B, Nogal B, Emery C, Summers C, Zheng K, Bayer R, et al. Characterization of the basic charge variants of a human IgG1 Effect of copper concentration in cell culture media. Mabs-Austin. 2011;3:577–583. doi:10.4161/mabs.3.6.17959.
   PubMed Web of Science ®Google Scholar
• Tsubaki M, Terashima I, Kamata K, Koga A. 2013. C-terminal modification of monoclonal antibody drugs: amidated species as a general product-related substance. Int J Biol Macromol. 52:139–147. doi:10.1016/j.ijbiomac.2012.09.016.
   PubMed Web of Science ®Google Scholar
• Dada OO, Jaya N, Valliere-Douglass J, Salas-Solano O. 2015. Characterization of acidic and basic variants of IgG1 therapeutic monoclonal antibodies based on non-denaturing IEF fractionation. Electrophoresis. 36:2695–2702. doi:10.1002/elps.201500219.
   PubMed Web of Science ®Google Scholar
• Campuzano IDG, Netirojjanakul C, Nshanian M, Lippens JL, Kilgour DPA, Van Orden S, Loo JA. Native-MS analysis of monoclonal antibody conjugates by Fourier Transform ion cyclotron resonance mass spectrometry. Anal Chem. 2018;90:745–751. doi:10.1021/acs.analchem.7b03021.
   PubMed Web of Science ®Google Scholar
• Xu W, Jimenez RB, Mowery R, Luo H, Cao M, Agarwal N, Ramos I, Wang X, Wang J. A Quadrupole Dalton-based multi-attribute method for product characterization, process development, and quality control of therapeutic proteins. Mabs-Austin. 2017;9:1186–1196. doi:10.1080/19420862.2017.1364326.
   PubMed Web of Science ®Google Scholar
• Rogers RS, Abernathy M, Richardson DD, Rouse JC, Sperry JB, Swann P, Wypych J, Yu C, Zang L, Deshpande R. A View on the Importance of “Multi-Attribute Method” for measuring purity of biopharmaceuticals and improving overall control strategy. Aaps J. 2017;20:7. doi:10.1208/s12248-017-0168-3.
   PubMed Web of Science ®Google Scholar
• Rogers RS, Nightlinger NS, Livingston B, Campbell P, Bailey R, Balland A. 2015. Development of a quantitative mass spectrometry multi-attribute method for characterization, quality control testing and disposition of biologics. Mabs-Austin. 7:881–890. doi:10.1080/19420862.2015.1069454.
   PubMed Web of Science ®Google Scholar